Evidence map›Paper›PMID 41960312›Full record

ArticleResearch square2026

A Transgenic Syrian Hamster Model for New World Hemorrhagic Fever Mammarenavirus Infection.

Samantha R Wasson, Yanan Liu, Minghao Li, Kevin W Bailey, Jonna B Westover, Julio Landinez-Aponte, Arnaud Van Wettere, Venkatraman Siddharthan, Christopher J Davies, Tracy R Daniels-Wells and 4 more

Abstract readPreprint
In one paragraph

Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Samantha R WassonUtah State University.
Yanan LiuUtah State University.
Minghao LiUtah State University.
Kevin W BaileyUtah State University.
Jonna B WestoverUtah State University.
Julio Landinez-AponteUtah State University.
Arnaud Van WettereUtah State University.
Venkatraman SiddharthanUtah State University.
Christopher J DaviesUtah State University.
Tracy R Daniels-WellsUniversity of California, Los Angeles.
Rong LiUtah State University.
Manuel L PenichetUniversity of California, Los Angeles.
Zhongde WangUtah State University.
Brian B GowenUtah State University.

Funding

Antibody-based therapeutic strategy for New World mammarenavirus hemorrhagic feverR01AI173769 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Brian B. Gowen, MANUEL L PENICHET · 2023 to 2026
$3.0M
Human TfR1-expressing hamsters to model New World arenaviral hemorrhagic feverR03AI156591 · NIAID · UTAH STATE UNIVERSITY · PI GOWEN, BRIAN B., WANG, ZHONGDE · 2021 to 2022
$146k
NIAID NIH HHS R01 AI173769NIAID NIH HHS R03 AI156591
6 · The paper itself

Abstract

Mammarenaviruses are endemic in rodent populations worldwide, and their zoonotic transmission can lead to a severe, life-threatening hemorrhagic fever (HF) syndrome. In the Americas, five New World mammarenaviruses (NWMs) are known to cause HF. In the absence of FDA-licensed vaccines or antiviral therapies, these viruses pose a significant public health risk and a threat to national security. Research into NWM pathogenesis and the development of effective countermeasures is severely limited by the lack of small-animal models that faithfully reproduce human disease. The pathogenic NWMs use human transferrin receptor 1 (hTfR1) as the receptor for cellular entry. Here, we describe the development of an hTfR1 knock-in (KI) golden Syrian hamster line and its susceptibility to Junín virus (JUNV) infection. This transgenic hamster infection model supports TfR1-mediated entry as an essential step in JUNV pathogenesis and provides a novel small-animal model to advance the development of promising host receptor-directed therapies and direct-acting antivirals to improve outcomes in patients with severe disease caused by pathogenic NWMs.

Indexed as

arenavirushamster modelJunín virusmammarenavirustransferrin receptor 1

Identifiers

PMID41960312
PMCPMC13060500

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.